Eversept Partners as of March 31, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 56 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Quality Care Properties | 9.3 | $20M | 1.0M | 19.43 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 7.3 | $16M | 60k | 263.15 | |
R1 Rcm | 6.3 | $14M | 1.9M | 7.14 | |
Radius Health Com New | 5.6 | $12M | 334k | 35.94 | |
Aerie Pharmaceuticals | 5.3 | $11M | 211k | 54.25 | |
Ablynx Nv Sponsored Adr | 4.6 | $9.9M | 182k | 54.56 | |
Avexis | 4.5 | $9.7M | 78k | 123.58 | |
Arena Pharmaceuticals Com New | 4.4 | $9.5M | 242k | 39.50 | |
Alnylam Pharmaceuticals (ALNY) | 4.4 | $9.4M | 79k | 119.10 | |
Glaxosmithkline Sponsored Adr | 4.2 | $8.9M | 227k | 39.49 | |
Ensign (ENSG) | 4.0 | $8.6M | 326k | 26.34 | |
Zogenix Com New | 3.8 | $8.2M | 205k | 40.05 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $7.3M | 45k | 162.98 | |
Array BioPharma | 2.7 | $5.8M | 358k | 16.32 | |
Sanofi Sponsored Adr (SNY) | 2.6 | $5.5M | 138k | 40.08 | |
Nevro (NVRO) | 2.4 | $5.3M | 61k | 86.67 | |
Teligent | 2.4 | $5.2M | 1.6M | 3.36 | |
Sage Therapeutics (SAGE) | 1.8 | $3.9M | 24k | 161.07 | |
BioMarin Pharmaceutical (BMRN) | 1.7 | $3.7M | 46k | 81.07 | |
Tesaro | 1.4 | $2.9M | 52k | 57.14 | |
Argenx Se Sponsored Adr (ARGX) | 1.3 | $2.9M | 36k | 80.44 | |
Abbott Laboratories (ABT) | 1.3 | $2.9M | 48k | 59.92 | |
Tg Therapeutics (TGTX) | 1.0 | $2.1M | 150k | 14.20 | |
Abiomed | 1.0 | $2.1M | 7.1k | 290.99 | |
Myokardia | 1.0 | $2.0M | 42k | 48.80 | |
Invacare Corporation | 0.8 | $1.7M | 100k | 17.40 | |
Deciphera Pharmaceuticals | 0.8 | $1.7M | 85k | 20.04 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 0.7 | $1.6M | 24k | 65.40 | |
Puma Biotechnology (PBYI) | 0.7 | $1.6M | 23k | 68.05 | |
Caretrust Reit (CTRE) | 0.7 | $1.5M | 108k | 13.61 | |
Anthem (ELV) | 0.6 | $1.3M | 6.0k | 219.70 | |
Medicines Company | 0.6 | $1.3M | 39k | 32.94 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $1.1M | 65k | 16.90 | |
Haemonetics Corporation (HAE) | 0.5 | $1.1M | 15k | 73.16 | |
Centene Corporation (CNC) | 0.5 | $1.1M | 10k | 106.87 | |
eHealth (EHTH) | 0.5 | $1.1M | 75k | 14.31 | |
Epizyme | 0.5 | $1.0M | 57k | 17.75 | |
Magellan Health Com New | 0.5 | $994k | 9.3k | 107.10 | |
Global Blood Therapeutics In | 0.4 | $860k | 18k | 48.30 | |
Align Technology (ALGN) | 0.3 | $753k | 3.0k | 251.13 | |
Amarin Corp Spons Adr New (AMRN) | 0.3 | $753k | 250k | 3.01 | |
Iradimed (IRMD) | 0.3 | $735k | 51k | 14.40 | |
Affimed Therapeutics B V | 0.3 | $716k | 387k | 1.85 | |
BioCryst Pharmaceuticals (BCRX) | 0.3 | $711k | 149k | 4.77 | |
Dynavax Technologies Corp Com New (DVAX) | 0.3 | $596k | 30k | 19.85 | |
Arbutus Biopharma (ABUS) | 0.3 | $588k | 118k | 5.00 | |
Albireo Pharma | 0.3 | $587k | 18k | 32.57 | |
Melinta Therapeutics | 0.3 | $569k | 77k | 7.40 | |
Foamix Pharmaceuticals SHS | 0.3 | $552k | 108k | 5.13 | |
Aquinox Pharmaceuticals | 0.2 | $450k | 32k | 14.08 | |
Ophthotech | 0.2 | $409k | 149k | 2.74 | |
Envision Healthcare | 0.2 | $366k | 9.5k | 38.43 | |
MiMedx Call Option (MDXG) | 0.2 | $335k | 48k | 6.97 | |
Seaspine Holdings | 0.1 | $313k | 31k | 10.14 | |
Dermira | 0.1 | $160k | 20k | 7.99 | |
Quotient SHS | 0.0 | $50k | 11k | 4.71 |